Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

Journal of Clinical Investigation

Volumn 98, Issue 1, 1996, Pages 24-29

  Lentz, Steven R ^a,b   Sobey, Christopher G ^a   Piegors, Donald J ^a   Bhopatkar, Monica Y ^a   Faraci, Frank M ^a   Malinow, M René ^c   Heistad, Donald D ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

acetylcholine; atherosclerosis; endothelium; homocysteine; thrombomodulin

Indexed keywords

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; HOMOCYSTEINE; NITROPRUSSIDE SODIUM; THROMBOMODULIN;

AMINO ACID BLOOD LEVEL; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM; HOMOCYSTINURIA; MONKEY; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; THROMBOCYTE ACTIVATION; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION;

EID: 0030015522     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118771     Document Type: Article

References (34)

1. Boushey, C.J., S.A.A. Beresford, G.S. Omenn, and A.G. Motulsky. 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274:1049-1057.
2. Stampfer, M.J., and M.R. Malinow. 1995. Can lowering homocysteine levels reduce cardiovascular risk? N. Engl. J. Med. 332:328-329.
3. Stamler, J.S., J.A. Osborne, O. Jaraki, L.E. Rabbani, M. Mullins, D. Singel, and J. Loscalzo. 1993. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 91:308-318.
4. Rodgers, G.M., and M.T. Conn. 1990. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 75:895-901.
5. Lentz, S.R., and J.E. Sadler. 1991. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J. Clin. Invest. 88:1906-1914.
6. Rodgers, G.M., and W.H. Kane. 1986. Activation of endogenous Factor V by a homocysteine-induced vascular endothelial cell activator. J. Clin. Invest. 77:1909-1916.
7. Fryer, R.H., B.D. Wilson, D.B. Gubler, L.A. Fitzgerald, and G.M. Rodgers. 1993. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler. Thromb. 13:1327-1333.
8. Hajjar, K.A. 1993. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J. Clin. Invent. 91:2873-2879.
9. Jacobsen, D.W. 1993. Cardiovascular disorders (risk assessment). Anal. Biochem. 65:367R-373R.
10. Mudd, S.H., H.L. Levy, and F. Skovby. 1995. Disorders of transsulfuration. In The Metabolic and Molecular Basis of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill, Inc., New York. 1279-1327.
11. Kang, S., P.W.K. Wong, and M.R. Malinow. 1992. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu. Rev. Nutr. 12:279-298.
12. Fleagle, S.R., M.R. Johnson, C.J. Wilbricht, R.F. Wilson, C.W. White, M.L. Marcus, and S.M. Collins. 1989. Automated analysis of coronary arterial morphology in cineangiograms: geometric and physiological validation in humans. IEEE Trans. Med. Imaging. 89:387-400.
13. Kaul, S., D.D. Heistad, A. Mugge, M.L. Armstrong, D.J. Piegors, and A.G. Lopez. 1991. Vascular responses to platelet activation in normal and atherosclerotic primates in vivo. Arterioscler. Thromb. 11:1745-1751.
14. Benzuly, K.H., R.C. Padgett, S. Kaul, D.J. Piegors, M.L. Armstrong, and D.D. Heistad. 1994. Functional improvement precedes structural regression of atherosclerosis. Circulation. 89:1810-1818.
15. Raife, T.J., D.J. Lager, K.C. Madison, W.W. Piette, E.J. Howard, M.T. Sturm, Y. Chen, and S.R. Lentz. 1994. Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation. J. Clin. Invest. 93:1846-1851.
16. Smolin, L.A., and J.A. Schneider. 1988. Measurement of total plasma cysteamine using high-performance liquid chromatography with electrochemical detection. Anal. Biochem. 168:374-379.
17. Malinow, M.R., S.S. Kang, L.M. Taylor, P.K.W. Wong, B. Coull, T. Inahara, D. Mukerjee, G. Sexton, and B. Upson. 1989. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 79:1180-1188.
18. Malinow, M.R., G. Sexton, M. Averbuch, M. Grossman, D. Wilson, and B. Upson. 1990. Homocyst(e)inemia in daily practice: levels in coronary artery disease. Coron. Artery Dis. 1:215-220.
19. von Clauss, A. 1957. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta. Haematol. 17:237.
20. Kjeldsberg, C. 1993. Normal blood and bone marrow values in man. In Wintrobe's Clinical Hematology. G.R. Lee, T.C. Bithell, J. Foerster, J.W. Athens, and J.N. Lukens, editors. Lea & Febiger, Philadelphia. 2297-2309.
21. Selhub, J., P.F. Jacques, P.W. Wilson, D. Rush, and I.H. Rosenberg. 1993. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J. Am. Med. Assoc. 270:2693-2698.
22. Selhub, J., P.F. Jacques, A.G. Bostom, R.B. D'Agostino, P.W.F. Wilson, A.J. Belanger, D.H. O'Leary, P.A. Wolf, E.J. Schaefer, and I.H. Rosenberg. 1995. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. N. Engl. J. Med. 332:286-291.
23. Freiman, P.C., G.G. Mitchell, D.D. Heistad, M.L. Armstrong, and D.G Harrison. 1986. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ. Res. 58:783-789.
24. Ludmer, P.L., A.P. Selwyn, T.L. Shook, R.R. Wayne, G.H. Mudge, R.W. Alexander, and P. Ganz. 1986. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 315:1046-1051.
25. Creager, M.A., J.P. Cooke, M.E. Mendelsohn, S.J. Gallagher, S.M. Coleman, J. Loscalzo, and V.J. Dzau. 1990. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86:228-234.
26. Harrison, D.G., M.L. Armstrong, P.C. Freiman, and D.D. Heistad. 1987. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J. Clin. Invest. 80:1808-1811.
27. Celermajer, D.S., K. Sorensen, M. Ryalls, J. Robinson, O. Thomas, J.V. Leonard, and J.E. Deanfield. 1993. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J. Am. Coll. Cardiol. 22:854-858.
28. Faraci, F.M., K. Orgren, and D.D. Heistad. 1994. Impaired relaxation of the carotid artery during activation of ATP-sensitive potassium channels in atherosclerotic monkeys. Stroke. 25:178-182.
29. Houston, D.S., J.T. Shepherd, and P.M. Vanhoutte. 1986. Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries: role of serotonin, thromboxane A2, and adenine nucleotides. J. Clin. Invest. 78:539-544.
30. Willerson, J.T., D.H. Hillis, M.W. Winneford, and L.M. Buja. 1986. Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. J. Am. Coll. Cardiol. 8:245-250.
31. Mudd, S.H., F. Skovby, H.L. Levy, K.D. Pettigrew, B. Wilcken, R.E. Pyeritz, G. Andria, G.H.J. Boers, I.L. Bromberg, R. Cerone, et al. 1985. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am. J. Hum. Genet. 37:1-31.
32. Lentz, S.R., and J.E. Sadler. 1993. Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood. 81:683-689.
33. Mudd, S.H., and H.L. Lew. 1995. Plasma homocyst(e)ine or homocysteine? N. Engl. J. Med. 333:325.
34. Starkebaum, G., and J.M. Harlan. 1986. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1370-1376.